EMA postpones data disclosure policy, but no new implementation date
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has confirmed that the implementation of its new policy on clinical trial data disclosure will be delayed well beyond the original 1 January 2014 implementation date because of the need to clarify aspects such as the publication of clinical study reports and the de-identification of patient data.